Crossing the Species Barrier: Developing Humanized Rodent Models to Optimize Transability into the Clinic
Time: 9:00 am
day: Day Two
Details:
• Developing a rodent model with xenotransplanted human cells to investigate neuroimmunology targets of interest
• Assessing chimeric cell functionality in model development
• Utilizing humanized rodent models to identify the contribution of human microglia to neurodegenerative disease pathogenesis and advance microglia as a therapeutic target
